OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit www.conferenceseries.com

Back

Fakhir Salman

Fakhir Salman

Mutah University, Jordan

Title: Fibrin sealant-Bi mechanical properties and bio-compatibility

Biography

Fakhir Al-Ani has completed his M.Sc. study and PhD study from Baghdad University ,College of Medicine. School of Medicine. He spend about 30 yars as a teaching staff in medical college. He is now working in Mutah University, Medicl College as the head of Physiology & Pathology Dept. He has supervised more than 13 Ph.D thesis, and more than 23 M.Sc. thesis. He has published more than 35 papers in reputed journals.

Abstract

Fibrin sealant “fibrin glue" is a unique surgical hemostatic/adhesive material. It is a natural, biocompatible and biodegradable material, resembling the final step of the coagulation cascade. It is composed of cryoprecipitate, thrombin and anti-fibrinolytic agent. Fibrin sealant is being utilized with increasing frequency in a variety of surgical situations with a wide range of clinical applications for suture support, tissue adhesion, and hemostasis. In clinical use, many factors may influence the outcome like; the time of clotting onset, the duration before lysis, biocompatibility, as well as some of its biomechanical properties such as tensile strength and elasticity. The aim of this study was to assess the optimization of the biomechanical criteria which are important for the surgeons for each specific surgical task. The method that we use is to synthesis fibrin glue with different concentrations and additions (tranexamic acid, platelets). Then we monitor the clotting times, durations need for clot to lysis, as well as explore the biomechanical behavior (tensile strength and elasticity). Synthesis of the glue revealed significant increase clotting times and durations for clot lysis when cryoprecipitate concentration was increased and when tranexamic acid or platelets are added to the glue. The elasticity tests clarified that the increase of cryoprecipitate concentration or tranexamic acid addition to fibrin glue formula caused significant higher elasticity. On the other hand, platelets or both tranexamic acid and platelets additions caused significant decrease elasticity results, which increase with time. The tension tests revealed that the increase of cryoprecipitate concentration or additions of platelets or both tranexamic acid and platelets caused significant higher resistance to tension, and this resistance decreases with time, while the addition of tranexamic acid alone causes a significant decrease in tension results, which increase with time. The biocompatibility was studied for all the components by a rat models with severed sciatic nerve was employed to evaluate the clinical efficacy of the glue. The results present gradual clinical improvement of the paralyzed leg with symmetrical bilateral movements at 6 weeks to 2 months duration. In conclusion, changing the concentration of the cryoprecipitate in relation to the thrombin and the addition of tranexamic acid and or platelet can change the duration, elasticity and tensile strength to make it compatible for specific operation.